TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INDUCE-SEQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

INDUCE-SEQ

ST13

US500000079362452

Class

1, 5, 9, 10, 42, 44

Filing

79362452

Registration

7410775

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

12/14/2024

Classification

Registered

Trademark type

Word

Nice classes

1, 5, 9, 10, 42, 44

Filing date

08/04/2022

Registration date

06/11/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/11/2024

Last transaction

06/11/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

STEINPFAD, SARAH

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

BROKEN STRING BIOSCIENCES LIMITED

Representatives

Brendan J. Hughes Cooley LLP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biological preparations for use in agriculture, except fungicides, herbicides, insecticides, and parasiticides

Class 5

Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; pharmaceutical preparations for use in gene and cell therapies for the treatment of cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; pharmaceutical preparations for use in chemotherapies; diagnostic kits for medical purposes comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; analytical test kits being medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders

Class 9

Downloadable computer software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; downloadable mobile application software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; apparatus and instruments for scientific or research purposes, namely, laboratory apparatus and instruments for genome sequencing, not for medical purposes

Class 10

Blood test collection kits comprised of blood collection needles, blood collecting tubes, and blood collection bags for medical purposes; radiation therapy devices

Class 42

Analytical laboratory services, namely, scientific laboratory services; pharmaceutical research and development services; testing, inspection, research and development of pharmaceutical preparations for gene therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapies; genome scientific research services; development of new technology for others in the field of medical devices and medical diagnostic apparatuses; medical research services; medical research in the field of infectious disease monitoring and surveillance services; research and development services in the field of antibodies; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; medical research in the field of oncology; toxicity testing and analysis for foodstuffs for scientific research purposes; toxicity testing and analysis for household products for scientific research purposes; computer software development; providing temporary use of online non-downloadable software and software applications using artificial intelligence for medical analysis; software as a service (SaaS) featuring software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; platform as a service (PaaS) featuring computer software platforms for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis

Class 44

Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical diagnostic blood testing for identifying and determining the presence and stage of diseases; genome editing therapeutics

Publications

History of USPTO decisions and trademark events.

37 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/14/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/21/2024

FIMP

FINAL DISPOSITION PROCESSED

11/21/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/11/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/11/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/11/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/26/2024

PUBO

PUBLISHED FOR OPPOSITION

03/26/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/06/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/06/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/21/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

02/21/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/21/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

02/21/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/21/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/05/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/05/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/05/2024

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

10/12/2023

RFNT

REFUSAL PROCESSED BY IB

08/01/2023

ATRV

ATTORNEY REVIEW COMPLETED

07/25/2023

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

07/19/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/08/2023

RFRR

REFUSAL PROCESSED BY MPU

07/08/2023

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

06/11/2023

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

06/10/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/31/2023

CNRT

NON-FINAL ACTION WRITTEN

05/30/2023

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

05/26/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/26/2023

CNRT

NON-FINAL ACTION WRITTEN

05/25/2023

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

05/24/2023

DOCK

ASSIGNED TO EXAMINER

05/23/2023

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

04/03/2023

MAFR

APPLICATION FILING RECEIPT MAILED

02/15/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/11/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/09/2023

Continuous trademark protection

Get notified about every new filing that threatens INDUCE-SEQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.